Filing Details

Accession Number:
0001238403-24-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-04 17:57:26
Reporting Period:
2024-06-03
Accepted Time:
2024-06-04 17:57:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238403 K Daniel Spiegelman 322 North 2200 West
Salt Lake City UT 84116
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-03 3,788 $22.04 36,705 No 4 S Direct
Common Stock Disposition 2024-06-04 3,788 $22.05 32,917 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.